Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Cardiology|December 20, 2018
Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trialJeremie Abtan, Gregory Ducrocq, Ph Gabriel Steg, et al.
The American Journal of Cardiology|November 7, 2015
Factors Associated With Infarct-Related Artery Patency Before Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the FAST-MI 2010 Registry)Clotilde Bailleul, Etienne Puymirat, Nadia Aissaoui, et al.
Archives of Cardiovascular Diseases|August 1, 2024
Rationale and design of the French Observatory of Acute Heart Failure (OFICA2)Claire Bouleti, Benjamin Alos, Damien Legallois, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 27, 2025
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohortBenjamin Alos, Claire Bouleti, Damien Legallois, et al.
American Heart Journal|March 24, 2022
Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCIGregory Ducrocq, Deepak L Bhatt, Jane J Lee, et al.
Clinical Cardiology|January 6, 2021
Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trialGregory Ducrocq, Gonzalo Calvo, José Ramón González-Juanatey, et al.
American Heart Journal|April 30, 2017
Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromesGregory Ducrocq, Phillip J Schulte, Andrzej Budaj, et al.
JAMA Network Open|November 1, 2024
Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT TrialFrançois M Carrier, Howard A Cooper, Gerard T Portela, et al.
Open Heart|December 12, 2017
Early clinical outcomes as a function of use of newer oral P2Y<sub>12</sub> inhibitors versus clopidogrel in the EUROMAX trialKurt Huber, Gregory Ducrocq, Christian W Hamm, et al.
The Canadian Journal of Cardiology|February 26, 2024
Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup AnalysisGregory Ducrocq, Marine Cachanado, Tabassome Simon, et al.
Pageof 10